ENLV (enlivex.com) Sof foyda

ENLV (enlivex.com) - kompaniyaning tovar belgisi

Enlivex Therapeutics (ENLV) sepsis uchun hayotni saqlab qoluvchi davolashni ta'minlovchi Allocetra tufayli narxlarni belgilash imkoniyatiga ega. Immun hujayralarini qayta dasturlashdagi innovatsiyalar sitokin bo'ronlarini yumshatish imkonini beradi, FDA ning qat'iy tartibga soluvchi qoidalari esa raqobatchilar uchun kirish to'siqlarini yaratadi. Kompaniyaning GURU.Markets vaqt trayektoriyasidagi umumiy foydasi fundamental tendentsiyani namoyish etadi, bunda 1.25 bozor shovqinlarini hisobga olmaganda, ushbu metrikaning darajasini ko'rsatadi.

ENLV (Enlivex Therapeutics) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

enlivex.com (ENLV) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Enlivex Therapeutics Ltd.|ENLV - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Enlivex Therapeutics|ENLV - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Enlivex Therapeutics|ENLV - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi enlivex.com|ENLV - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Enlivex Therapeutics|ENLV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics Ltd.|ENLV - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Enlivex Therapeutics|ENLV - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Enlivex Therapeutics|Shoshilinch likvidlik enlivex.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ENLV - Sof foyda
Kompaniyaning jamlanma tahlili:Enlivex Therapeutics
Enlivex Therapeutics Ltd asosiy tovari

Enlivex Therapeutics (ENLV) kompaniyasining operatsion natijasi sof foyda kapitalizatsiyasi dinamikasini aniq aks ettiradi, u har bir birlik aksiyadorlik kapitali uchun kunlik topilgan mablaglar hajmi sifatida hisoblanadi. Ushbu ko'rsatkich sepsis terapiyasining 2-bosqich sinovlari natijalari kutilayotgan vaqtda biznesning real samaradorligini baholash imkonini beradi va investorga emitentning erta klinik sinovlar bilan bog'liq tebranishlardan qat'i nazar, qiymat yaratish qobiliyatidan signal beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Kompaniyaning sof daromadi Pharming Corp|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniya foydasi UPB|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof foyda GOSS|Sof moliyaviy natija KalVista Corp|Septerna Inc - Sof daromad|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|Kompaniyaning sof daromadi Rigel Pharma|ANAB (AnaptysBio Corp) - Sof daromad|Kompaniya foydasi ATXS|Sof daromad ENGN|RAPT: Yakuniy foyda|Sof daromad JBIO (Aerovate Therapeutics Inc)|Soliqlar to‘langandan keyingi foyda ACRS|Sof foyda KYTX (Kyverna)|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Avalo Therapeutics, Inc. - Yakuniy foyda|ELDN (Eledon) - Sof foyda|Sof foyda Agenus, Inc|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|ZURA: Soliqdan keyingi foyda|Sof foyda ATYR (aTyr Pharma)|Adagene Inc (ADAG) - Kompaniyaning sof daromadi|IMA: Sof daromad|STTK - Sof foyda|EQ (equilliumbio.com) - Sof daromad|CNTB: Soliqlar to‘langandan keyingi foyda|IMUX (Immunic Therapeutics) - Sof foyda|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|Sof daromad X4 Pharmaceuticals, Inc XFOR|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|Sof moliyaviy natija Celularity Inc (CELU)|INmune Bio - Sof foyda|Kompaniyaning sof daromadi Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|Kompaniya foydasi SABS|Kompaniyaning sof foydasi Akari Therapeutics|Kompaniyaning sof foydasi QTTB|Sof daromad GOVX (GeoVax)|Kompaniyaning sof foydasi EDSA (Edesa Biotech Inc)|Kompaniyaning sof foydasi iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Soliqdan keyingi foyda|XTL Biopharmaceuticals - Sof foyda|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi